Featured Research

from universities, journals, and other organizations

UVa Scientists Discover New Type Of Nerve Cell That Could Be Target For Drugs To Ease Pain

Date:
September 22, 2005
Source:
University of Virginia Health System
Summary:
Experts say up to two percent of the US population suffers from neuropathic pain. But this pain generally responds poorly to analgesics and other standard treatment and get worse over time, causing permanent disability in some people. Now there may be new hope for these pain sufferers.

CHARLOTTESVILLE, Va., Sept. 21, 2005 -- We all know that if you putyour hand over an open flame it's very painful. What you may not knowis that, for some people, just lying under a blanket is painful aswell. They have neuropathic pain--annoying, chronic pain that comesfrom a diseased nerve cell rather than a specific stimulus. Feelingphantom pain in a missing limb is another, more famous, example.

Experts say up to two percent of the U.S. population suffers fromneuropathic pain. But this pain generally responds poorly to analgesicsand other standard treatment and get worse over time, causing permanentdisability in some people. Now there may be new hope for these painsufferers.

Scientists at the University of Virginia Health System have identifieda new type of pain-sensing neuron in rats, which are unusually dense ina subtype of calcium channels called T-type channels. It is possiblethat these "T-rich cells" could be targets for future therapies totreat neuropathic pain as well as acute onset pain, which can happenafter invasive surgery or inflammation.

A UVa anesthesiologist, Dr. Slobodan Todorovic, and his colleaguesidentified these novel cells and believe that the T-type calciumchannels in them may serve as a volume control for pain impulses. "Wehope that this new type of neuron will be amenable to new therapies.The next step will be to find a drug to block the action of thesecalcium channels," Todorovic said.

It was once thought that calcium channels were only important for brainfunction. But, Todorovic and his team show that the T-type channels areimportant to the functioning of peripheral nerves, especially when thenerves are injured.

A PhD student in UVa's neuroscience graduate program, Mike Nelson,discovered these T-rich nerve cells in Todorovic' lab. "It's veryexciting to make an initial observation like this," Nelson said. "It'sone reason we go to grad school in the first place." There are no drugsnow that effectively treat neuropathic pain, Nelson added. "Hopefully,observations like this will lead to new and more efficacious drugs inthe future. Our findings are another piece of evidence that thesecalcium channels are excellent targets for new analgesic development."

###

Their findings are published in the Sept. 21st issue of The Journal of Neuroscience found online at http://www.jneurosci.org/.


Story Source:

The above story is based on materials provided by University of Virginia Health System. Note: Materials may be edited for content and length.


Cite This Page:

University of Virginia Health System. "UVa Scientists Discover New Type Of Nerve Cell That Could Be Target For Drugs To Ease Pain." ScienceDaily. ScienceDaily, 22 September 2005. <www.sciencedaily.com/releases/2005/09/050922014547.htm>.
University of Virginia Health System. (2005, September 22). UVa Scientists Discover New Type Of Nerve Cell That Could Be Target For Drugs To Ease Pain. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2005/09/050922014547.htm
University of Virginia Health System. "UVa Scientists Discover New Type Of Nerve Cell That Could Be Target For Drugs To Ease Pain." ScienceDaily. www.sciencedaily.com/releases/2005/09/050922014547.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins